19-39248513-CTT-CT
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The ENST00000634967.1(IFNL4):c.66delA(p.Gly23AlafsTer110) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 13877 hom., cov: 0)
Exomes 𝑓: 0.31 ( 53187 hom. )
Consequence
IFNL4
ENST00000634967.1 frameshift
ENST00000634967.1 frameshift
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.00
Genes affected
IFNL4 (HGNC:44480): (interferon lambda 4 (gene/pseudogene)) This gene is a polymorphic pseudogene which, in some humans, encodes the interferon (IFN) lambda 4 protein. Humans are polymorphic for the dinucleotide TT/deltaG allele. Compared to the ancestral state in non-human primates, the TT allele produces a frameshift in the coding region of this gene which is predicted to induce nonsense-mediated mRNA decay. This allele, and an allele in the first intron of this gene, have experienced a rapid increase in frequency and show indications of positive selection. The ancestral states of these alleles are associated with an impaired ability to clear hepatitis C virus. This gene, like other type III interferons (IFNs), interacts with the IFN lambda receptor complex (IFNLR) whose signaling is generally restricted to epithelial cells. This gene resides in a cluster of four type III IFN genes and at least two pseudogenes on chromosome 19q13.2. In general, interferons are produced in response to viral infection and block viral replication and propagation to uninfected cells by activating the JAK-STAT pathway and up-regulating antiviral genes. Multiple alternatively spliced transcripts have been described for this gene but their biological validity and protein coding status is still being ascertained. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.629 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNL4 | NR_074079.1 | n.343delA | non_coding_transcript_exon_variant | Exon 1 of 5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFNL4 | ENST00000634967.1 | c.66delA | p.Gly23AlafsTer110 | frameshift_variant | Exon 1 of 4 | 1 | ENSP00000489559.1 | |||
IFNL4 | ENST00000606380.2 | c.66delA | p.Gly23AlafsTer158 | frameshift_variant | Exon 1 of 5 | 1 | ENSP00000476098.2 | |||
IFNL4 | ENST00000634680.1 | c.66delA | p.Gly23AlafsTer86 | frameshift_variant | Exon 1 of 3 | 1 | ENSP00000489240.1 |
Frequencies
GnomAD3 genomes AF: 0.396 AC: 60151AN: 151764Hom.: 13844 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
60151
AN:
151764
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.222 AC: 4AN: 18 AF XY: 0.125 show subpopulations
GnomAD2 exomes
AF:
AC:
4
AN:
18
AF XY:
Gnomad AFR exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.306 AC: 330720AN: 1079170Hom.: 53187 Cov.: 0 AF XY: 0.306 AC XY: 156109AN XY: 509462 show subpopulations
GnomAD4 exome
AF:
AC:
330720
AN:
1079170
Hom.:
Cov.:
0
AF XY:
AC XY:
156109
AN XY:
509462
Gnomad4 AFR exome
AF:
AC:
14892
AN:
22948
Gnomad4 AMR exome
AF:
AC:
3391
AN:
8412
Gnomad4 ASJ exome
AF:
AC:
5576
AN:
14376
Gnomad4 EAS exome
AF:
AC:
2298
AN:
26516
Gnomad4 SAS exome
AF:
AC:
4718
AN:
19484
Gnomad4 FIN exome
AF:
AC:
5488
AN:
21104
Gnomad4 NFE exome
AF:
AC:
280064
AN:
919770
Gnomad4 Remaining exome
AF:
AC:
13360
AN:
43646
Heterozygous variant carriers
0
15422
30845
46267
61690
77112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
10648
21296
31944
42592
53240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.397 AC: 60233AN: 151882Hom.: 13877 Cov.: 0 AF XY: 0.387 AC XY: 28714AN XY: 74234 show subpopulations
GnomAD4 genome
AF:
AC:
60233
AN:
151882
Hom.:
Cov.:
0
AF XY:
AC XY:
28714
AN XY:
74234
Gnomad4 AFR
AF:
AC:
0.635706
AN:
0.635706
Gnomad4 AMR
AF:
AC:
0.378796
AN:
0.378796
Gnomad4 ASJ
AF:
AC:
0.393249
AN:
0.393249
Gnomad4 EAS
AF:
AC:
0.0686388
AN:
0.0686388
Gnomad4 SAS
AF:
AC:
0.233928
AN:
0.233928
Gnomad4 FIN
AF:
AC:
0.240128
AN:
0.240128
Gnomad4 NFE
AF:
AC:
0.317373
AN:
0.317373
Gnomad4 OTH
AF:
AC:
0.372391
AN:
0.372391
Heterozygous variant carriers
0
1693
3386
5079
6772
8465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
530
1060
1590
2120
2650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
696
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at